MGMT and central nervous system cancer: Restoring GLS2 expression in T96G glioma cells inhibited cell proliferation, survival, and migration; furthermore, it increased cell sensitivity to alkylating agents like temozolamide (TMZ) and carmustine by downregulating O6-methylguanine-DNA methyltransferase (MGMT) [156,157].